Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 2829-2836

  Li, Jingwei ^a   Jiang, Kailei ^a   Zhao, Fujie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; Icariin; MicroRNA 21; Ovarian cancer; PTEN; RECK

Indexed keywords

CASPASE 3; ICARIIN; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN RECK; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; FLAVONOID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN; RECK PROTEIN, HUMAN;

A2780 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR MECHANICS; OVARIAN CANCER CELL LINE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE;

EID: 84928905560     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3891     Document Type: Article

References (39)

1. Luo J, Zhou J, Cheng Q, Zhou C and Ding Z: Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett 7: 1043-1048, 2014.
2. Tang AQ, Cao XC, Tian L, He L and Liu F: Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3-derived sphere-forming cells. Mol Med Rep 11: 2221-2226, 2015.
3. Hays JL, Kim G, Walker A, Annunziata CM, Lee JM, Squires J, Houston N, Steinberg SM and Kohn EC: A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety. Mol Clin Oncol 1: 565-569, 2013.
4. Chen WC, Lin MS, Ye YL, Gao HJ, Song ZY and Shen XY: microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer. Exp Ther Med 3: 1039-1048, 2012.
5. Jiang JX, Zhang N, Liu ZM and Wang YY: Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: A meta-analysis. Asian Pac J Cancer Prev 15: 7583-7588, 2014.
6. Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C and Bourguignon LY: The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol 132: 739-744, 2014.
7. Liu S, Fang Y, Shen H, Xu W and Li H: Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. Acta Biochim Biophys Sin 45: 756-762, 2013.
8. Yang L, Kuang LG, Zheng HC, Li JY, Wu DY, Zhang SM and Xin Y: PTEN encoding product: A marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 9: 35-39, 2003.
9. Wu H, Wang K, Liu W and Hao Q: PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression. Biochem Biophys Res Commun 444: 141-146, 2014.
10. Lau MT, Klausen C and Leung PC: E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression. Oncogene 30: 2753-2766, 2011.
11. Lou Y, Yang X, Wang F, Cui Z and Huang Y: MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 26: 819-827, 2010.
12. Zhou X, Huang S, Jiang L, Zhang S, Li W, Chen Z and Zhang D: Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Oncol Lett 7: 1549-1555, 2014.
13. Xue G, Zou X, Zhou JY, Sun W, Wu J, Xu JL and Wang RP: Raddeanin A induces human gastric cancer cells apoptosis and inhibits their invasion in vitro. Biochem Biophys Res Commun 439: 196-202, 2013.
14. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, et al: RECK expression in pancreatic cancer: Its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9: 1779-1784, 2003.
15. Zhang Y, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q and Pang D: Low expression of RECK indicates a shorter survival for patients with invasive breast cancer. Cancer Sci 103: 1084-1089, 2012.
16. Qi Q, Lu N, Li C, Zhao J, Liu W, You Q and Guo Q: Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells. Mol Carcinog: Feb 14, 2014 (Epub ahead of print). doi: 10.1002/mc.22138.
17. Fejzo MS, Ginther C, Dering J, Anderson L, Venkatesan N, Konecny G, Karlan B and Slamon DJ: Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK. Genes Chromosomes Cancer 50: 434-441, 2011.
18. Ahn MY, Kang DO, Na YJ, Yoon S, Choi WS, Kang KW, Chung HY, Jung JH, Min do S and Kim HS: Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing. Cancer Lett 325: 189-199, 2012.
19. Sadahira K, Sagawa M, Nakazato T, Uchida H, Ikeda Y, Okamoto S, Nakajima H and Kizaki M: Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway. Int J Oncol 45: 2278-2286, 2014.
20. Xie YL, Yang YJ, Tang C, Sheng HJ, Jiang Y, Han K and Ding LJ: Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells. Clin Transl Oncol 16: 898-905, 2014.
21. Ma C, Yin G, You F, Wei Y, Huang Z, Chen X and Yan D: A specific cell-penetrating peptide induces apoptosis in SKOV3 cells by down-regulation of Bcl-2. Biotechnol Lett 35: 1791-1797, 2013.
22. Yang L, Wang Y, Guo H and Guo M: Synergistic anti-cancer effects of icariin and temozolomide in glioblastoma. Cell Biochem Biophys: Nov 11, 2014 (Epub ahead of print).
23. Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY and Wei S: Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol 11: 890-898, 2011.
24. Wang Q, Hao J, Pu J, Zhao L, Lü Z, Hu J, Yu Q, Wang Y, Xie Y and Li G: Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4. Int J Oncol 39: 973-980, 2011.
25. Nakamura K, Banno K, Yanokura M, Iida M, Adachi M, Masuda K, Ueki A, Kobayashi Y, Nomura H, Hirasawa A, et al: Features of ovarian cancer in Lynch syndrome (Review). Mol Clin Oncol 2: 909-916, 2014.
26. Li S, Li Y, Wen Z, Kong F, Guan X and Liu W: microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells. Mol Med Rep 9: 1703-1708, 2014.
27. Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, et al: Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett 298: 222-230, 2010.
28. Zhang DC, Liu JL, Ding YB, Xia JG and Chen GY: Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-eKB. Acta Pharmacol Sin 34: 301-308, 2013.
29. Wang B and Zhang Q: The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 138: 1659-1666, 2012.
30. Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y and Bi F: miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 585: 2998-3005, 2011.
31. Zhang C, Shi YR, Liu XR, Cao YC, Tian JL, Jia ZY, Zhen D, Liu FH and Gao JM: The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21. Theriogenology 82: 461-468, 2014.
32. Waite KA and Eng C: Protean PTEN: Form and function. Am J Hum Genet 70: 829-844, 2002.
33. Gu J, Tamura M and Yamada KM: Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143: 1375-1383, 1998.
34. Alexius-Lindgren M, Andersson E, Lindstedt I and Engström W: The RECK gene and biological malignancy - its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res 34: 3867-3873, 2014.
35. Prosdócimi FC, Rodini CO, Sogayar MC, Sousa SC, Xavier FC and Paiva KB: Calcifying cystic odontogenic tumour: Immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN). J Oral Pathol Med 43: 545-553, 2014.
36. + regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosis. Int Immunopharmacol 11: 212-219, 2011.
37. Li J, Sun GZ, Lin HS, Pei YX, Qi X, An C, Yu J and Hua BJ: The herb medicine formula 'Yang Wei Kang Liu' improves the survival of late stage gastric cancer patients and induces the apoptosis of human gastric cancer cell line through Fas/Fas ligand and Bax/Bcl-2 pathways. Int Immunopharmacol 8: 1196-1206, 2008.
38. Yao Y, Huang C, Li ZF, Wang AY, Liu LY, Zhao XG, Luo Y, Ni L, Zhang WG and Song TS: Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway. World J Gastroenterol 15: 1751-1758, 2009.
39. Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One 9: e103698, 2014.